Medical device-induced thrombosis: what causes it and how can we prevent it?
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Medical device-induced thrombosis: what causes it and how can we prevent it?
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume 13, Issue -, Pages S72-S81
Publisher
Wiley
Online
2015-06-21
DOI
10.1111/jth.12961
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis
- (2015) Harry R. Büller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heparin-Mimicking Multilayer Coating on Polymeric Membrane via LbL Assembly of Cyclodextrin-Based Supramolecules
- (2014) Jie Deng et al. ACS Applied Materials & Interfaces
- Factor XII inhibition reduces thrombus formation in a primate thrombosis model
- (2014) A. Matafonov et al. BLOOD
- Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits
- (2014) Jonathan W. Yau et al. BLOOD
- Factor XI as a target for antithrombotic therapy
- (2014) Charles E. Bane et al. DRUG DISCOVERY TODAY
- Applications of elastin-like polypeptides in drug delivery
- (2014) Sarah R. MacEwan et al. JOURNAL OF CONTROLLED RELEASE
- A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk
- (2014) M. Larsson et al. Science Translational Medicine
- Only high levels of dabigatran attenuate catheter thrombosis in vitro and in rabbits
- (2014) Jonathan W. Yau et al. THROMBOSIS AND HAEMOSTASIS
- Immobilization of heparin/poly-l-lysine nanoparticles on dopamine-coated surface to create a heparin density gradient for selective direction of platelet and vascular cells behavior
- (2013) Tao Liu et al. Acta Biomaterialia
- Antithrombotic Effect of Antisense Factor XI Oligonucleotide Treatment in Primates
- (2013) Jeffrey R. Crosby et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
- (2013) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Corn trypsin inhibitor coating attenuates the prothrombotic properties of catheters in vitro and in vivo
- (2012) Jonathan W. Yau et al. Acta Biomaterialia
- Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway
- (2012) M. J. Krisinger et al. BLOOD
- Device thrombogenicity emulation: A novel methodology for optimizing the thromboresistance of cardiovascular devices
- (2012) Danny Bluestein et al. JOURNAL OF BIOMECHANICS
- Dual surface modification with PEG and corn trypsin inhibitor: Effect of PEG:CTI ratio on protein resistance and anticoagulant properties
- (2012) Sara Alibeik et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Surface modification with polyethylene glycol–corn trypsin inhibitor conjugate to inhibit the contact factor pathway on blood-contacting surfaces
- (2011) Sara Alibeik et al. Acta Biomaterialia
- Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo
- (2011) J. W. Yau et al. BLOOD
- Water-soluble argatroban for antithrombogenic surface coating of tissue-engineered cardiovascular tissues
- (2011) Yasuhide Nakayama et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
- Bioactivity and Platelet Adhesion Study of a Human Thrombomodulin-Immobilized Nitinol Surface
- (2009) Hsi-Yi Yeh et al. JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
- Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI
- (2008) E. I. Tucker et al. BLOOD
- Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary Syndromes
- (2008) Shamir R. Mehta et al. CIRCULATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started